Request Expert

Expert has worked with a number of pharmaceutical and life science companies at senior level as either employee, consultant or interim manager, supporting initial public offerings and other fundraising activities and cross-border M&A. He has particular skills in due dilgence, valuation, market assessment, competetive inteligence and product positioning, which have been successfully applied in the licensing of a variety of pharmaceutical products and technologies, including early and late-stage cancer drugs, urology and sexual dysfunction drugs and in developing business stratgies appropriate for start-up and micro-cap companies. He is comfortable working with companies of all sizes.

Development of global licensing strategy and supporting collateral (valuation, competitor intelligence) for a novel male sexual health productValuation of intellectual property portfolio held by privatised arm of UK defense technology company, development of market models and licensing scenarios to support investment from a private equity fundLicensing of consumer health medications and the enabling technology on behalf of a private US companyAnalysis of opportunities, strategies and tactics appropriate to the acquisition of late-stage/marketed pharmaceutical products (CNS indications) on behalf of a listed UK companyAnalysis of the portfolio held by a therapeutic vaccines company on behalf of a potential investor